Morphine Market Analysis

  • Report ID: 3602
  • Published Date: Sep 09, 2025
  • Report Format: PDF, PPT

Morphine Market Segmentation:

Application Segment Analysis

In application segmentation, the pain management segment is projected to capture morphine market share of over 69% by 2035. If the patient's pain cannot be managed with regular pain relievers, then the patient is prescribed morphine sustained-release tablets to relieve severe pain. Opioids play an important role in ensuring adequate analgesia in acute postoperative situations. According to the Centers for Disease Control and Prevention in 2022 physicians prescribed approximately 37% of all opioid prescriptions in the U.S.

Mode of Administration Segment Analysis

In terms of mode of administration, the oral segment in the morphine market is expected to observe the highest CAGR during the forecast period. The oral segment includes morphine in oral tablet and pharmaceutical form. Orlando Clinical Research Center found that 30 minutes for most oral medication to dissolve in the bloodstream. Oral medicines are considered one of the easiest ways that can be taken by the patients themselves without anyone’s help.

Our in-depth analysis of the global morphine market includes the following segments:

Application

  • Pain Management
  • Diarrhea Suppressant

Mode of Administration

  • Injection
  • Oral

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of morphine is estimated at USD 21.91 billion.

The global morphine market size was over USD 20.88 billion in 2025 and is anticipated to witness a CAGR of around 5.5%, crossing USD 35.67 billion revenue by 2035.

The North America morphine market will hold around 35% share by 2035, driven by increasing patient pool of osteoporosis, high geriatric population, and growing healthcare investments and awareness.

Key players in the market include Verve Health Care Ltd., Mayne Pharma Group, Daiichi Sankyo Company Limited, Hikma Pharmaceuticals USA, AbbVie Inc., Mylan N.V., Sun Pharmaceutical Industries Ltd., Alcaliber S.A., Mallinckrodt Pharmaceuticals, AstraZeneca plc.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos